CIK 0001267565
- Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- Phone
- +1 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-01-20 | Heffernan Michael Thomas Chairman, President and CEO | Grant or award | +18,135 | 373,444 | ||
| 2016-01-20 | Heffernan Michael Thomas Chairman, President and CEO | Grant or award · Stock Option (Right to Purchase) | +109,005 | 109,005 | ||
| 2016-01-20 | Brannelly Paul Executive Vice President & CFO | Grant or award | +4,913 | 77,376 | ||
| 2016-01-20 | Brannelly Paul Executive Vice President & CFO | Grant or award · Stock Option (Right to Purchase) | +29,475 | 29,475 | ||
| 2015-09-10 | Hirsch David Director | Grant or award · Stock Option (Right to Purchase) | +15,000 | 15,000 | ||
| 2015-09-10 | Nadav Eran Director | Grant or award · Stock Option (Right to Purchase) | +15,000 | 15,000 | ||
| 2015-09-10 | SANTINI GINO Director | Grant or award · Stock Option (Right to Purchase) | +15,000 | 15,000 | ||
| 2015-09-10 | Freund John Gordon Director | Grant or award · Stock Option (Right to Purchase) | +15,000 | 15,000 | ||
| 2015-09-10 | Heron Patrick J Director | Grant or award · Stock Option (Right to Purchase) | +15,000 | 15,000 | ||
| 2015-05-14 | Heffernan Michael Thomas Chairman, President and CEO | Grant or award · Stock Option (Right to Purchase) | +70,193 | 70,193 | ||
| 2015-05-14 | Duke Barry S See remarks | Grant or award · Stock Option (Right to Purchase) | +27,537 | 27,537 | ||
| 2015-05-14 | Brannelly Paul Executive Vice President & CFO | Grant or award · Stock Option (Right to Purchase) | +22,929 | 22,929 | ||
| 2015-05-12 | Longitude Capital Partners, LLC 10% owner | Conversion | +3,060,502 | 3,060,502 | ||
| 2015-05-12 | Longitude Capital Partners, LLC 10% owner | Purchase | +196,070 | $12.00 | $2.4M | 3,256,572 |
| 2015-05-12 | Longitude Capital Partners, LLC 10% owner | Conversion | +61,340 | 61,340 | ||
| 2015-05-12 | Longitude Capital Partners, LLC 10% owner | Purchase | +3,930 | $12.00 | $47K | 65,270 |
| 2015-05-12 | Longitude Capital Partners, LLC 10% owner | Conversion · Series B Convertible Preferred Stock | −12,837,935 | 0 | ||
| 2015-05-12 | Longitude Capital Partners, LLC 10% owner | Conversion · Series B Convertible Preferred Stock | −257,303 | 0 | ||
| 2015-05-12 | Longitude Capital Partners, LLC 10% owner | Conversion · Series C Convertible Preferred Stock | −3,160,905 | 0 | ||
| 2015-05-12 | Longitude Capital Partners, LLC 10% owner | Conversion · Series C Convertible Preferred Stock | −63,356 | 0 |
Page 38 of 41 · 811 trades